BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 24.11.2004

Draft Risk Assessment of Streptogramin Resistance in Enterococcus faecium Attributable to the Use of Streptogramins in Animals; Availability

The Food and Drug Administration (FDA) is announcing the availability of, and is requesting comment on, a draft risk assessment of the potential impact that food-animal use of streptogramin antimicrobials has on the resistance to chemically similar streptogramins used to treat human enterococcal infections. The veterinary drug of interest in this risk assessment is the streptogramin, virginiamycin, a drug approved for use in chicken, turkey, swine, and cattle feed. FDA will consider information received during the comment period in its preparation of a final risk assessment.

Source: Federal Register — Food and Drug AdministrationOpen original release →